Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1977 2
1978 1
1980 2
1982 1
1984 1
1985 2
1988 1
1989 3
1990 4
1991 2
1992 3
1993 4
1994 4
1995 3
1996 5
1997 1
1998 1
1999 5
2000 4
2001 2
2002 2
2003 6
2004 4
2005 3
2006 4
2007 8
2008 4
2009 3
2010 4
2011 3
2012 2
2013 3
2014 7
2015 9
2016 6
2017 4
2018 2
2019 5
2020 5
2021 4
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

137 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Recurrent Childhood Hodgkin Lymphoma"
Page 1
The epidemiology of osteosarcoma.
Ottaviani G, Jaffe N. Ottaviani G, et al. Cancer Treat Res. 2009;152:3-13. doi: 10.1007/978-1-4419-0284-9_1. Cancer Treat Res. 2009. PMID: 20213383 Review.
The incidence rates and 95% confidence intervals of osteosarcoma for all races and both sexes are 4.0 (3.5-4.6) for the range 0-14 years and 5.0 (4.6-5.6) for the range 0-19 years per year per million persons. Among childhood cancers, osteosarcoma occurs eighth in general …
The incidence rates and 95% confidence intervals of osteosarcoma for all races and both sexes are 4.0 (3.5-4.6) for the range 0-14 years and …
Nivolumab in children and young adults with relapsed or refractory solid tumours or lymphoma (ADVL1412): a multicentre, open-label, single-arm, phase 1-2 trial.
Davis KL, Fox E, Merchant MS, Reid JM, Kudgus RA, Liu X, Minard CG, Voss S, Berg SL, Weigel BJ, Mackall CL. Davis KL, et al. Lancet Oncol. 2020 Apr;21(4):541-550. doi: 10.1016/S1470-2045(20)30023-1. Epub 2020 Mar 17. Lancet Oncol. 2020. PMID: 32192573 Free PMC article. Clinical Trial.
Eligible patients for part B (dose-expansion phase) were aged 1-30 years with measurable disease (by RECIST criteria) in the following disease cohorts: rhabdomyosarcoma, Ewing sarcoma, osteosarcoma, neuroblastoma, Hodgkin lymphoma, non-Hodgkin …
Eligible patients for part B (dose-expansion phase) were aged 1-30 years with measurable disease (by RECIST criteria) in the followin …
Chlorambucil-induced seizures.
Salloum E, Khan KK, Cooper DL. Salloum E, et al. Cancer. 1997 Mar 1;79(5):1009-13. doi: 10.1002/(sici)1097-0142(19970301)79:5<1009::aid-cncr18>3.0.co;2-5. Cancer. 1997. PMID: 9041164 Review.
Underlying diseases included nephrotic syndrome (n = 12 cases), solid tumors (n - 10 cases), non-Hodgkin's lymphoma (n = 3 cases), and chronic lymphocytic leukemia (n = 1 case). ...Nine of 14 adults received high dose chlorambucil in Phase I-II studies or as part of …
Underlying diseases included nephrotic syndrome (n = 12 cases), solid tumors (n - 10 cases), non-Hodgkin's lymphoma (n = 3 cas …
Hydroa vacciniforme-like lymphoproliferative disorder in Korea.
Han B, Hur K, Ohn J, Kim TM, Jeon YK, Kim YC, Mun JH. Han B, et al. Sci Rep. 2020 Nov 9;10(1):19294. doi: 10.1038/s41598-020-76345-2. Sci Rep. 2020. PMID: 33168864 Free PMC article.
Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein-Barr virus (EBV)-associated lymphoproliferative disease. The disease course of HVLPD varies from an indolent course to progression to aggressive lymphoma. ...HVLPD has various cli …
Hydroa vacciniforme-like lymphoproliferative disorder (HVLPD) is a rare Epstein-Barr virus (EBV)-associated lymphoproliferative disease …
Hodgkin lymphoma in children and adolescents: improving the therapeutic index.
Kelly KM. Kelly KM. Hematology Am Soc Hematol Educ Program. 2015;2015:514-21. doi: 10.1182/asheducation-2015.1.514. Hematology Am Soc Hematol Educ Program. 2015. PMID: 26637767 Review.
Hodgkin lymphoma (HL) is a highly curable form of childhood cancer, with estimated 5 year survival rates exceeding 98%. ...
Hodgkin lymphoma (HL) is a highly curable form of childhood cancer, with estimated 5 year survival rates exceeding 98%. …
Treatment of pediatric lymphoma in Japan: Current status and plans for the future.
Kobayashi R, Sunami S, Mitsui T, Nakazawa A, Koga Y, Mori T, Tanaka F, Ueyama J, Osumi T, Fukano R, Ohki K, Sekimizu M, Mori T; Lymphoma Committee; Japanese Pediatric Leukemia/Lymphoma Study Group. Kobayashi R, et al. Pediatr Int. 2015 Aug;57(4):523-34. doi: 10.1111/ped.12725. Pediatr Int. 2015. PMID: 26096060 Review.
Results of pediatric lymphoma treatment have improved markedly over the past 30 years. In Hodgkin's lymphoma, the 5 year event-free survival (EFS) was 81.5% in a retrospective study. ...Moreover, the 2 year EFS rate was 81% in Japanese advanced stage patients …
Results of pediatric lymphoma treatment have improved markedly over the past 30 years. In Hodgkin's lymphoma, the 5 yea …
Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: Report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study).
Rahiman EA, Bakhshi S, Deepam Pushpam, Ramamoorthy J, Das A, Ghara N, Kalra M, Kapoor G, Meena JP, Siddaigarhi S, Thulkar S, Sharma MC, Srinivasan R, Trehan A. Rahiman EA, et al. Pediatr Hematol Oncol. 2022 Aug;39(5):391-405. doi: 10.1080/08880018.2021.2002485. Epub 2022 Jan 3. Pediatr Hematol Oncol. 2022. PMID: 34978257
The literature on B-non-Hodgkin lymphoma (NHL) in India is restricted to individual hospital data. ...Hypoalbuminemia was noted in 82/170 (48.2%). Histological subtypes: Burkitt lymphoma (BL): 69.6%, Burkitt-like: 10.4%, and diffuse large B cell lymphoma …
The literature on B-non-Hodgkin lymphoma (NHL) in India is restricted to individual hospital data. ...Hypoalbuminemia was note …
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
Englund A, Hopstadius C, Enblad G, Gustafsson G, Ljungman G. Englund A, et al. Acta Oncol. 2015 Jan;54(1):41-8. doi: 10.3109/0284186X.2014.948058. Epub 2014 Sep 9. Acta Oncol. 2015. PMID: 25203597 Free PMC article.
BACKGROUND: Hodgkin lymphoma (HL) in children constitutes approximately 30% of all pediatric lymphomas in Sweden. ...Male sex was over-represented, especially in lower age groups and in nodular lymphocyte predominant Hodgkin lymphoma (NLPHL). In nodula …
BACKGROUND: Hodgkin lymphoma (HL) in children constitutes approximately 30% of all pediatric lymphomas in Sweden. ...Male sex …
Non-Hodgkin lymphoma and pre-existing conditions: spectrum, clinical characteristics and outcome in 213 children and adolescents.
Attarbaschi A, Carraro E, Abla O, Barzilai-Birenboim S, Bomken S, Brugieres L, Bubanska E, Burkhardt B, Chiang AK, Csoka M, Fedorova A, Jazbec J, Kabickova E, Krenova Z, Lazic J, Loeffen J, Mann G, Niggli F, Miakova N, Osumi T, Ronceray L, Uyttebroeck A, Williams D, Woessmann W, Wrobel G, Pillon M; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the International Berlin-Frankfur t-Münster (i-BFM) Study Group. Attarbaschi A, et al. Haematologica. 2016 Dec;101(12):1581-1591. doi: 10.3324/haematol.2016.147116. Epub 2016 Aug 11. Haematologica. 2016. PMID: 27515251 Free PMC article.
Children and adolescents with pre-existing conditions such as DNA repair defects or other primary immunodeficiencies have an increased risk of non-Hodgkin lymphoma. However, large-scale data on patients with non-Hodgkin lymphoma and their entire spectr …
Children and adolescents with pre-existing conditions such as DNA repair defects or other primary immunodeficiencies have an increased risk …
Relapse localization in Danish pediatric patients with Hodgkin lymphoma.
Lundgaard AY, Hjalgrim LL, Dejanovic D, Berthelsen AK, Schomerus E, Wendtland P, Specht L, Maraldo MV. Lundgaard AY, et al. Acta Oncol. 2021 May;60(5):658-666. doi: 10.1080/0284186X.2021.1881817. Epub 2021 Mar 12. Acta Oncol. 2021. PMID: 33710948
BACKGROUND: Pediatric Hodgkin lymphoma (pHL) is highly curable. However, a minority experience relapse and are subjected to toxic salvage regimens. ...The lymphoma volumes involved at diagnosis and at relapse were contoured on the patients' original scans. .. …
BACKGROUND: Pediatric Hodgkin lymphoma (pHL) is highly curable. However, a minority experience relapse and are subjected to to …
137 results